|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Product revenues, net | |||||
| Product revenues, net | |||||
| Other revenues | |||||
| Total product revenues, net | |||||
| Costs and expenses: | |||||
| Cost of sales | |||||
| Research and development expenses | |||||
| Acquired in-process research and development expenses | |||||
| Selling, general and administrative expenses | |||||
| Intangible asset impairment charge | |||||
| Change in fair value of contingent consideration | |||||
| Total costs and expenses | |||||
| Income (loss) from operations | |||||
| Interest income | |||||
| Interest expense | |||||
| Other expense, net | |||||
| Income before provision for income taxes | |||||
| Provision for income taxes | |||||
| income (loss) | |||||
| Net income (loss) per common share: | |||||
| Basic (in dollars per share) | |||||
| Diluted (in dollars per share) | |||||
| Shares used in per share calculations: | |||||
| Basic (in shares) | |||||
| Diluted (in shares) |
Loading...